3.1. Patient Characteristics
deaths, aneurysm
ADVERSE EVENTS, ANEURYSM
A total of 60 patients were included and randomized. Eight patients left the study, including two deaths unrelated to the study and reported as severe adverse events. Their data were analyzed on an ITT basis. Sixty patients were retained to participate in the analysis (The eligibility criteria (inclusion criteria and non-inclusion criteria) were all met, with the exception of the age limit of 75 years, which was exceeded for one 79-year-old patient (protocol deviation). No difference was observed in the number of days of treatment between the TNS (9.5 days; min: 4, max: 10) vs. the sham group (9.9 days; min: 7, max: 10, The patient baseline characteristics are presented in All the baseline assessments are presented in The characteristics of aneurysm treatment are presented in 